Form D To Observe: Cognition Therapeutics $3.00 million Financing. Kenneth I Moch Submitted Nov 30 Filing

Biotechnology Cognition Therapeutics Inc - Kenneth I Moch

Cognition Therapeutics Financing

Cognition Therapeutics Inc, Corporation just released form D for $3.00 million equity financing. This is a new filing. Cognition Therapeutics was able to finance itself with $3.00 million. That is 100.00% of the financing round. The total financing amount was $3.00 million. This form was filed on 2016-11-30. The reason for the financing was: unspecified. The fundraising still has about $95 more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Cognition Therapeutics is based in Pennsylvania. The filler’s business is Biotechnology. The form D was signed by Kenneth I Moch President and Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 2403 Sidney Street, Suite 261, Pittsburgh, Pa, Pennsylvania, 15203. Kenneth Moch is the related person in the form and it has address: C/O Cognition Therapeutics, Inc., 2403 Sidney Street, Suite 261, Pittsburgh, Pa, Pennsylvania, 15203. Link to Cognition Therapeutics Filing: 000145536516000005.

Analysis of Cognition Therapeutics Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Cognition Therapeutics sold 100.00% of the offering. The financing is still open. Could this mean that the trust in Cognition Therapeutics is high? The average financing size for companies in the Biotechnology industry is $3.08 million. The offering was 2.60% smaller than the average of $3.08 million. Of course this should not be seen as negative. Companies get financed for a variety of needs and reasons. The minimum investment for this financing was set at $2432. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Cognition Therapeutics Also

The Form D signed by Kenneth I Moch might help Cognition Therapeutics Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment